Unknown

Dataset Information

0

DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy.


ABSTRACT: DNA-methylation (DNAm) levels at age-associated CpG sites can be combined into epigenetic aging signatures to estimate donor age. It has been demonstrated that the difference between such epigenetic age-predictions and chronological age is indicative for of all-cause mortality in later life. In this study, we tested alternative epigenetic signatures and followed the hypothesis that even individual age-associated CpG sites might be indicative for life-expectancy. Using a 99-CpG aging model, a five-year higher age-prediction was associated with 11% greater mortality risk in DNAm profiles of the Lothian Birth Cohort 1921 study. However, models based on three CpGs, or even individual CpGs, generally revealed very high offsets in age-predictions if applied to independent microarray datasets. On the other hand, we demonstrate that DNAm levels at several individual age-associated CpGs seem to be associated with life expectancy - e.g., at CpGs associated with the genesPDE4C and CLCN6. Our results support the notion that small aging signatures should rather be analysed by more quantitative methods, such as site-specific pyrosequencing, as the precision of age-predictions is rather low on independent microarray datasets. Nevertheless, the results hold the perspective that simple epigenetic biomarkers, based on few or individual age-associated CpGs, could assist the estimation of biological age.

SUBMITTER: Lin Q 

PROVIDER: S-EPMC4789590 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy.

Lin Qiong Q   Weidner Carola I CI   Costa Ivan G IG   Marioni Riccardo E RE   Ferreira Marcelo R P MR   Deary Ian J IJ   Wagner Wolfgang W  

Aging 20160201 2


DNA-methylation (DNAm) levels at age-associated CpG sites can be combined into epigenetic aging signatures to estimate donor age. It has been demonstrated that the difference between such epigenetic age-predictions and chronological age is indicative for of all-cause mortality in later life. In this study, we tested alternative epigenetic signatures and followed the hypothesis that even individual age-associated CpG sites might be indicative for life-expectancy. Using a 99-CpG aging model, a fiv  ...[more]

Similar Datasets

| S-EPMC4925819 | biostudies-literature
| S-EPMC6781367 | biostudies-literature
| S-EPMC5004144 | biostudies-literature
| S-EPMC7687708 | biostudies-literature
| S-EPMC8770732 | biostudies-literature
| S-EPMC2441810 | biostudies-literature
| S-EPMC9715628 | biostudies-literature
| S-EPMC3919014 | biostudies-literature
| S-EPMC4914085 | biostudies-literature
| S-EPMC5836973 | biostudies-literature